Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,127 public trials 3,991 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS

NCT05795140

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +18 more
Locations
  • Novartis Investigative Site São Paulo, Brazil
  • Novartis Investigative Site Rio de Janeiro, Brazil
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Ostrava, Poruba, Czechia
View Trial Details
Recruiting

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

NCT06941389

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Children's of Alabama (MRD-HCT) Birmingham, Alabama, United States
  • Children's of Alabama (NT-DMT) Birmingham, Alabama, United States
  • Nemours Children's Hospital, Delaware (MRD-HCT) Wilmington, Delaware, United States
  • Children's National Hospital (MRD-HCT) Washington D.C., District of Columbia, United States
View all 37 locations
View Trial Details
Recruiting

Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain

NCT07624838

Conditions
CD30-Positive Peripheral T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hospital Universitario A Coruña A Coruña, Spain
  • Hospital Universitari Son Llàtzer Palma de Mallorca, Balearic Islands, Spain
  • Hospital Universitari Son Espases Palma de Mallorca, Balearic Islands, Spain
  • ICO Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
View all 37 locations
View Trial Details
Recruiting

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

NCT05848687

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Valley Children's Hospital Madera, California, United States
View all 24 locations
View Trial Details
Recruiting

A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

NCT07623616

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Chiba Aoba Municipal Hospital Chiba, Japan
  • Gifu Municipal Hospital Gifu, Japan
  • Hyogo Medical University Hospital Hyōgo, Japan
  • Mito Medical Center Ibaraki, Japan
View all 20 locations
View Trial Details

Related conditions